Literature DB >> 3021754

Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors.

R A Smith, M Kirstein, W Fiers, C Baglioni.   

Abstract

Recombinant murine and human tumor necrosis factor (mTNF and hTNF, respectively) were radioiodinated to high specific activity using a solid-phase lactoperoxidase method. A single class of high affinity receptors for 125I-TNF was identified on TNF-sensitive murine L cells and human HeLa S2 cells. Competitive radioligand binding assays were used to study the species specificity of TNF preparations. Unlabeled hTNF competed 30-fold less effectively than mTNF for binding to L cell receptors, whereas mTNF competed to approximately the same extent as hTNF for binding to HeLa cell receptors. A similar species specificity was observed in cytotoxicity assays; hTNF was more cytotoxic for HeLa cells than mTNF. Conversely, mTNF was more growth inhibitory and cytotoxic for L cells than hTNF. mTNF. and hTNF.receptor complexes were compared by gel filtration chromatography and polyacrylamide gel electrophoresis before and after cross-linking with bis[2-(succinimidooxycarbonyloxy)ethyl]sulfone (BSOCOES). These complexes eluted in gel filtration at a position corresponding to a globular protein of 350,000 Mr. Gel autoradiographs of the fractions containing cross-linked complexes showed bands of 95,000 and 75,000 Mr as well as small amounts of higher Mr bands. mTNF and hTNF treated with BSOCOES formed cross-linked dimers and trimers. Therefore, we were unable to determine whether the 95,000 and 75,000 Mr bands represented two distinct subunits of receptors or one subunit to which either a dimer or a monomer of TNF was cross-linked. These results demonstrate species specificity in the TNF-receptor interaction. In addition, the affinity labeling studies in two species give an identical pattern for the TNF X receptor complexes, suggesting that the receptors have similar subunit composition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021754

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Quantitative evaluation of the lengths of homobifunctional protein cross-linking reagents used as molecular rulers.

Authors:  N S Green; E Reisler; K N Houk
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

2.  Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor.

Authors:  S H Socher; M W Riemen; D Martinez; A Friedman; J Tai; J C Quintero; V Garsky; A Oliff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor.

Authors:  R G Goodwin; D Anderson; R Jerzy; T Davis; C I Brannan; N G Copeland; N A Jenkins; C A Smith
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

4.  Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents.

Authors:  J S Patton; P M Peters; J McCabe; D Crase; S Hansen; A B Chen; D Liggitt
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

Review 5.  Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition.

Authors:  K Pfizenmaier; M Krönke; P Scheurich; G A Nagel
Journal:  Blut       Date:  1987-07

6.  Species-specific TNF induction of thymocyte proliferation.

Authors:  M J Ehrke; R L Ho; K Hori
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

Authors:  M Lewis; L A Tartaglia; A Lee; G L Bennett; G C Rice; G H Wong; E Y Chen; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I.

Authors:  C L Selinsky; K L Boroughs; W A Halsey; M D Howell
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

9.  Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells.

Authors:  Michael D Milsom; Bernhard Schiedlmeier; Jeff Bailey; Mi-Ok Kim; Dandan Li; Michael Jansen; Abdullah Mahmood Ali; Michelle Kirby; Christopher Baum; Leslie J Fairbairn; David A Williams
Journal:  Blood       Date:  2009-03-06       Impact factor: 22.113

10.  Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.

Authors:  A J Beniers; R J van Moorselaar; W P Peelen; F M Debruyne; J A Schalken
Journal:  Urol Res       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.